Company Filing History:
3 out of 3,221 
1 out of 255 
Years Active: 2003-2009
Title: The Innovative Contributions of Sharon Erickson
Introduction
Sharon Erickson, an accomplished inventor based in Hillsborough, California, has made significant strides in the field of cancer therapies. With a total of three patents to her name, her work primarily revolves around innovative treatment methods that incorporate advanced biological compounds.
Latest Patents
Among her latest inventions are the patents titled "Methods of treatment using anti-ErbB antibody-maytansinoid conjugates." These patents focus on the development of methods for treating cancer through the use of anti-ErbB receptor antibody-maytansinoid conjugates. The applications detail particularly targeted therapies that aim to direct treatment towards ErbB receptors, highlighting a pioneering approach in cancer therapeutics.
Career Highlights
Sharon has had a remarkable career, contributing her expertise to prominent companies in the biopharmaceutical sector. She has worked with notable organizations such as Genentech, Inc. and Immunogen, Inc., where she refined her skills and contributed to cutting-edge research and development in cancer treatment.
Collaborations
Throughout her career, Sharon has collaborated with several notable professionals, including Ralph H. Schwall and Mark X. Sliwkowski. These partnerships have allowed her to elevate her research and innovations further, contributing to the collective goal of advancing cancer therapies.
Conclusion
Sharon Erickson stands out as a visionary inventor whose work is instrumental in shaping the future of cancer treatment. Through her patents and collaborations, she continues to pave the way for new therapeutic approaches, making significant contributions to the field of medical science and improving the lives of countless individuals facing cancer.